Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate liraglutide in
subjects with mild, moderate and severe degrees of hepatic impairment compared with subjects
with normal hepatic function.